Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
Thumbnail

TAVR provides comparable value for low-risk patients with bicuspid and tricuspid AS

Researchers examined data from more than 3,000 TAVR procedures performed with balloon-expandable valves. 

Thumbnail

Surgical explantation after TAVR failure: What cardiologists, and patients, should know

Redo TAVR is not always a feasible treatment option, researchers explained. TAVR explantation can be offered to a larger patient population. 

FDA approves 2 new tissue valves for structural heart disease patients

The next-generation devices were designed to be used without blood-thinners. 

Thumbnail

TEER benefits all HF patients with SMR, but men see more long-term benefits

The study's authors examined data from men and women who underwent TEER with the MitraClip device in addition to guideline-directed medical therapy. 

Thumbnail

Valve-in-valve TAVR a safe alternative for patients with failed bioprosthetic valves

The final decision between ViV TAVR and repeat SAVR, researchers said, should be based on multiple factors. 

Thumbnail

PCI before TAVR? New study provides answers, but questions remain

Researchers examined data from 17 different facilities, keeping a close eye on mortality and rehospitalization rates. 

New TAVR system for high-risk patients gains FDA approval

The system was specifically designed for patients who should avoid open-heart surgery.  

Thumbnail

Structural heart disease specialist takes helm of ACC patient engagement initiative

CardioSmart, an online resource for both patients and clinicians, has a new editor. 

Displaying 545 - 552 of 879
Design by Adaptive Theme